@article {4205,
	title = {Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study.},
	journal = {Lancet},
	year = {2014},
	month = {2014 Jul 26},
	abstract = {Interferon-free regimens are needed to treat hepatitis C virus (HCV) infections. We investigated the efficacy of combined simeprevir and sofosbuvir.},
	issn = {1474-547X},
	doi = {10.1016/S0140-6736(14)61036-9},
	author = {Lawitz, Eric and Sulkowski, Mark S and Ghalib, Reem and Rodriguez-Torres, Maribel and Younossi, Zobair M and Corregidor, Ana and DeJesus, Edwin and Pearlman, Brian and Rabinovitz, Mordechai and Gitlin, Norman and Lim, Joseph K and Pockros, Paul J and Scott, John D and Fevery, Bart and Lambrecht, Tom and Ouwerkerk-Mahadevan, Sivi and Callewaert, Katleen and Symonds, William T and Picchio, Gaston and Lindsay, Karen L and Beumont, Maria and Jacobson, Ira M}
}
